GenSight Biologics
SIGHT.PA
#9779
Rank
S$44.01 M
Marketcap
$0.34
Share price
2.17%
Change (1 day)
-40.96%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2023: -S$38.93 Million

According to GenSight Biologics's latest financial reports the company's current earnings are S$1.4 Million. In 2023 the company made an earning of -S$38.93 Million, an increase over its 2022 earnings that were of -S$39.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2023

Annual earnings

Year Earnings Change
2023-S$38.93 Million-2.16%
2022-S$39.79 Million-8.58%
2021-S$43.53 Million-22.54%
2020-S$56.19 Million21.01%
2019-S$46.44 Million-9.66%
2018-S$51.4 Million32.28%
2017-S$38.86 Million24.57%
2016-S$31.2 Million55.57%
2015-S$20.05 Million84%
2014-S$10.9 Million112.64%
2013-S$5.13 Million